The Type 1 IGF receptor plays a critical role in cell progression. Dur
ing normal ontogeny it is expressed by every proliferating cell, where
it functions as a potent cell survival agent. Disruption of the Type
1 IGF receptor gene by homologous recombination results in severely gr
owth retarded animals which invariably die at birth. Most importantly,
fibroblasts derived from mice embryos lacking the receptor cannot be
transformed by any of a number of oncogenes, indicating that the Type
1 IGF receptor displays potent mitogenic and antiapoptotic activities.
A number of transcription factors have been identified that control t
he expression of the IGF receptor promoter, thus stimulating cellular
proliferation. On the other hand, certain tumour suppressors including
p53 and WT1 were shown to repress the activity of the IGF receptor pr
omoter. Mutant forms of these and other tumour suppressors are potenti
ally impaired in their ability to suppress expression of the IGF recep
tor gene, thus helping to expand neoplastic populations. (C) 1998 Publ
ished by Elsevier Science Ireland Ltd. All rights reserved.